- Companies
- Nourish
Nourish Revenue, Valuation, Funding & Investors
Nourish is valued at $1.8B as of May 2026, a 10.9x multiple on its last reported $160M revenue.
Last Nourish valuation
$1.8B
Series C · May 2026
Last Nourish funding round
$100M
Series C · May 2026
Nourish revenue
$160M
Series C · May 2026
Key investors in Nourish
Y Combinator
Thrive Capital
Index Ventures
BoxGroup
Maverick Ventures
JPMorgan Growth Equity Partners
About Nourish
Nourish is a virtual nutrition care provider using AI to deliver insurance-covered dietitian services addressing chronic diseases. New York-headquartered since 2020, it matches patients with registered dietitians for personalized plans covered by Medicare and major plans, focusing on diabetes, hypertension, and weight management.
Founded
2021
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Services
Revenue
$160M (May 2026)
Valuation
$1.8B (May 2026)
Nourish Valuation
Nourish is currently valued at $1.8B, based on its Series C in May 2026.
The $100M round was led by Menlo Ventures and Reference Capital SA, with participation from Index Ventures, JPMorgan Growth Equity Partners and Thrive Capital.
Nourish's valuation has grown 1.8x from $1B at its Series B in April 2025 to $1.8B in May 2026, across 2 priced rounds.
Nourish valuation by funding round
Revenue multiple| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| May 2026 | Series C | $1.8B | 10.9x |
| Apr 2025 | Series B | $1B | 43.5x |
Nourish Revenue
Nourish's latest recorded revenue is $160M, as of its Series C in May 2026. At a $1.8B valuation, that implies a 10.9x revenue multiple.
Revenue grew from $23M in April 2025 to $160M in May 2026, while the revenue multiple moved from 43.5x to 10.9x.
Nourish revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| May 2026 | $160M | $1.8B | 10.9x | Series C |
| Apr 2025 | $23M | $1B | 43.5x | Series B |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Nourish Funding History
Nourish has raised a total of $213M across 5 funding rounds.
Nourish's first fundraising round was a $100K pre-seed round in November 2021. The most recent completed round was a $100M Series C in May 2026.
Nourish funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| May 2026 | Series C | Menlo Ventures (lead); Reference Capital SA (lead); Index Ventures; JPMorgan Growth Equity Partners; Thrive Capital | $100M | $1.8B | Nourish raised USD 100 million in a Series C financing led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners. The round valued the company at USD 1.75 billion and brought total funding to USD 215 million. The financing was structured as primary growth capital to support scale-up of its nutrition and metabolic care platform, including AI agents, clinical expansion, and payer partnerships. The company is positioned as a virtual nutrition and metabolic care provider focused on helping patients manage conditions linked to obesity, diabetes, cardiovascular disease, and GLP-1 therapy. Reported expansion plans from earlier financing included growing its network of dietitians from hundreds to more than 1,000, indicating a rapid operating build-out. The company’s care model centers on virtual nutrition counseling and clinically supported metabolic health services, with growth tied to broader payer adoption and expanded physician-led care delivery. Nourish previously completed a USD 35 million Series A led by Index Ventures, and the latest round reflects continued support from existing backers alongside new capital from Menlo Ventures. The company’s operating scale has been described through its expanding dietitian network and its push into AI-enabled clinical workflows, but no revenue or EBITDA figures were disclosed. |
| Apr 2025 | Series B | JPMorgan Growth Equity Partners (lead); Index Ventures; Y Combinator; BoxGroup; G Squared; Maverick Ventures; Pinegrove Capital Partners; Thrive Capital; Atomico | $70M | $1B | Nourish is an AI-powered nutrition counseling platform that connects patients with registered dietitians via telehealth for insurance-covered chronic disease management. The company delivers metabolic care through its virtual platform, which integrates artificial intelligence tools for meal tracking, wearable integrations, lab services, and clinical decision support for both patients and providers. In April 2025, Nourish announced a $70 million Series B funding round led by J.P. Morgan Growth Equity Partners, with participation from Thrive Capital, Index Ventures, Y Combinator, Maverick Ventures, BoxGroup, Atomico, G Squared, and Pinegrove Opportunity Partners, bringing total funding to $115 million. The company reported estimated annual revenue of $23 million as of 2025. By the time of the Series B announcement, Nourish had scaled to serve over 500,000 patients nationwide across all 50 states with a network of 6,000+ registered dietitians. The company demonstrated strong clinical outcomes, including an average weight loss of 8% and A1C reduction of 1.3%, along with an independently validated 3.1x ROI in year one for health plan partners. The funding was allocated to accelerate AI platform development, expand the registered dietitian network, deepen partnerships with health plans and provider organizations, and grow the team across functions. |
| Mar 2024 | Series A | Index Ventures (lead); Alex Morgan; Y Combinator; BoxGroup; TCV; Maverick Ventures; Thrive Capital | $35M | - | Nourish is a New York-based telenutrition platform founded in 2021 that connects patients across all 50 U.S. states with registered dietitians (RDs) for personalized virtual nutrition counseling covered by insurance, addressing chronic conditions like diabetes, heart health, eating disorders, autoimmune diseases, and cancer through its mobile app for meal logging, chatting, and progress tracking. The company serves tens of thousands of patients with hundreds of RDs, offering services at zero out-of-pocket cost to 94% of patients via partnerships with major health insurers, and focuses on preventative care by tackling poor nutrition as a root cause of America's healthcare crisis affecting over half of Americans. On March 27, 2024, Nourish raised $35 million in a Series A funding round led by Index Ventures, with participation from Maverick Ventures, TCV, existing investors Y Combinator, Thrive Capital, and BoxGroup, and angels including Alex Morgan and founders from Oscar, Olipop, and Notion, bringing total funding to $44 million. Proceeds will expand the RD network from hundreds to over 1,000 by end-2024 (a 20x increase since 2023), accelerate digital platform development for patients and providers, invest in AI for personalization and administrative streamlining, integrate 'food as medicine' features allowing RDs to prescribe tailored diets, and deepen insurance partnerships plus grocery delivery ties to address food insecurity and support GLP-1 medication outcomes. Nourish positions itself in the growing digital health tech sector, particularly New York-based nutrition and preventative care startups, emphasizing a win-win-win for patients (accessible care), RDs (reduced admin), and payers (better outcomes). |
| Feb 2023 | Seed | Thrive Capital (lead); Susa Ventures; Y Combinator; BoxGroup; Operator Partners | $8M | - | - |
| Nov 2021 | Pre-seed | Y Combinator (lead) | $100K | - | - |
Who has invested in Nourish?
15 investors have backed Nourish across its funding rounds, including Y Combinator, Thrive Capital, Index Ventures, BoxGroup, Maverick Ventures and JPMorgan Growth Equity Partners.
Lead investors include Menlo Ventures, Reference Capital SA, JPMorgan Growth Equity Partners, Index Ventures, Thrive Capital and 1 other investor.
Nourish Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Lead | Nov 2021 | ||
| 4 | Lead | Feb 2023 | ||
| 3 | Lead | Mar 2024 | ||
| 3 | Participant | Feb 2023 | ||
| 2 | Lead | Apr 2025 | ||
| 2 | Participant | Mar 2024 | ||
| 1 | Lead | May 2026 | ||
| 1 | Participant | Mar 2024 | ||
| 1 | Participant | Feb 2023 | ||
| 1 | Participant | Apr 2025 | ||
| 1 | Participant | Mar 2024 | ||
| 1 | Participant | Apr 2025 | ||
| 1 | Participant | Feb 2023 | ||
This data is available for Pro users. Sign up to see all 15 Nourish investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialNourish Competitors
Nourish competitors include listed companies like Teladoc, Talkspace, Hims and C3.ai, and private ones like Apricus Health and Headway.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $1.5B | - | ||
| Private | - | - | $2.3B | - | ||
| Publicly listed | $2.5B | $124M | $1.1B | 0.6x | ||
| Publicly listed | $229M | $6M | $871M | 3.4x | ||
| Publicly listed | $2.3B | $178M | $6.5B | 2.4x | ||
| Publicly listed | $250M | ($484M) | $1.7B | 4.5x |
Nourish Public Comps
Nourish is still privately-owned, but its public comps include C3.ai, Wenge AI, TRS Information Technology, Ping An Healthcare, JMDC, PCITECH, Compass Pathways, Haizhi, Fractal Analytics and Ncino.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $250M | ($484M) | 4.3x | 4.5x | (2.2x) | (6.2x) | |||
| $60M | ($20M) | 27.6x | - | (82.7x) | - | |||
| $76M | ($20M) | 19.3x | 19.7x | (73.5x) | 478.8x | |||
| $815M | $52M | 0.9x | 0.9x | 13.4x | 16.9x | |||
| $324M | $88M | 5.0x | 4.6x | 18.4x | 17.9x | |||
| $1.5B | $53M | 0.8x | 0.9x | 24.1x | - | |||
| - | ($293M) | - | - | (5.8x) | (8.4x) | |||
| $93M | ($30M) | 21.5x | 16.3x | (67.1x) | (440.4x) | |||
This data is available for Pro users. Sign up to see all Nourish competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Nourish
| When was Nourish founded? | Nourish was founded in 2021. |
| Where is Nourish headquartered? | Nourish is headquartered in New York City, NY, United States. |
| Is Nourish publicly listed? | No, Nourish is a private, VC-backed company. |
| What is Nourish's valuation? | Nourish was last valued at $1.8B in its Series C in May 2026. |
| How much funding has Nourish raised? | Nourish has raised $213M across 5 funding rounds. |
| What was Nourish's last funding round? | Nourish's last funding round was a $100M Series C in May 2026, led by Menlo Ventures and Reference Capital SA. |
| Who are Nourish's investors? | Nourish's investors include Y Combinator, Thrive Capital, Index Ventures, BoxGroup, JPMorgan Growth Equity Partners, Maverick Ventures, Menlo Ventures, Alex Morgan, Susa Ventures, G Squared and 5 others. |
| What is Nourish's revenue? | Nourish's latest recorded revenue is $160M (May 2026). |
| What is Nourish's revenue multiple? | Nourish's latest valuation implies a 10.9x revenue multiple ($1.8B valuation on $160M of revenue). |
| Which companies are comparable to Nourish? | Companies comparable to Nourish include Apricus Health, Headway, Teladoc, Talkspace, Hims and C3.ai. |
See companies similar to Nourish
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




